| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EYS | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CLASP1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BCKDHB | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | CETN3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | MORF4L1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | PHC1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | RP11-382A20.3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SEMA6C | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | C14orf28 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | TMEM189 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
